1. Bioorg Med Chem Lett. 2007 Apr 15;17(8):2171-8. doi:
10.1016/j.bmcl.2007.01.104.  Epub 2007 Feb 4.

Synthesis and structure-activity relationships of spirohydantoin-derived 
small-molecule antagonists of the melanin-concentrating hormone receptor-1 
(MCH-R1).

Rowbottom MW(1), Vickers TD, Tamiya J, Zhang M, Dyck B, Grey J, Schwarz D, Heise 
CE, Hedrick M, Wen J, Tang H, Wang H, Fisher A, Aparicio A, Saunders J, 
Goodfellow VS.

Author information:
(1)Department of Medicinal Chemistry, Neurocrine Biosciences Inc., 12790 El 
Camino Real, San Diego, CA 92130, USA. mrowbottom@neurocrine.com

The design, synthesis, and SAR of a series of substituted spirohydantoins are 
described. Optimization of an in-house screening hit gave compounds that 
exhibited potent binding affinity and functional activity at MCH-R1.

DOI: 10.1016/j.bmcl.2007.01.104
PMID: 17350839 [Indexed for MEDLINE]
